First, because circulating levels of angptl2 increase with age [29] and predict cardiovascular diseases [174], diabetes [175], and kidney diseases [176] in the general population, angptl2 was a candidate biomarker in the oldest individuals (from 85 to over 110 years old) [177]. Here, ANGPTL2 is linked to cardiovascular disorder.